The Mursa Protocol: A Novel Multimodal Antiseptic-Based DAIR Strategy for Early Hip Periprosthetic Joint Infection
Authors:
- Slavko ČičakSČSlavko Čičak
- Josip KocurJKJosip Kocur
- Dino GregorovićDGDino Gregorović
- David MatićDMDavid Matić
- Dalibor KristekDKDalibor Kristek
- Damjan DimnjakovićDDDamjan Dimnjaković
- Matej TomićMTMatej Tomić
- Ivan SabolISIvan Sabol
- Petra ČičakPČPetra Čičak
- Krunoslav ŠegoKŠKrunoslav Šego
- Gordana KristekGKGordana Kristek
- Ivana Haršanji DrenjančevićIDIvana Haršanji Drenjančević
Open Access
- 25 May 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (6) , 535
Abstract
Background: Debridement, antibiotics, and implant retention (DAIR) is an established treatment for early periprosthetic joint infection (PJI) following hip arthroplasty; however, reported success rates remain highly variable, particularly in patients with significant comorbidities, fracture-related arthroplasty, or resistant microorganisms. Augmentation of standard DAIR with structured local antimicrobial strategies may improve infection control but remains insufficiently standardized and evaluated. Methods: This retrospective single-center case series evaluated outcomes of a standardized multimodal DAIR-based strategy, the Mursa protocol, in 16 consecutive patients treated for early hip PJI between 2022 and 2025. PJI was diagnosed according to European Bone and Joint Infection Society criteria. The treatment included radical surgical debridement and exchange of mobile components with sequential intraoperative antiseptic microdebridement using povidone–iodine and hypochlorous/hypochlorite solution, followed by postoperative drain-based local antimicrobial irrigation and systemic antibiotic therapy. Treatment success was defined as sustained infection eradication with implant retention, absence of clinical and radiological signs of infection, no requirement for long-term suppressive antibiotics, and no infection-related mortality at a minimum one-year follow-up. Results: The cohort was clinically complex, with a predominance of arthroplasty procedures performed for fracture-related indications (11/16), a high comorbidity burden (median Charlson Comorbidity Index 5), revision arthroplasty in four patients, and a high rate of resistant or polymicrobial infections. At final follow-up, 15 of 16 patients (93.8%) achieved treatment success. One patient required implant removal due to persistent polymicrobial infection. No irrigation-related complications, wound-healing problems, or clinically relevant systemic toxicity were observed. Conclusions: In this high-risk cohort, a structured multimodal DAIR protocol incorporating sequential antiseptic microdebridement and postoperative local antimicrobial irrigation was feasible, safe, and associated with encouraging infection control. However, these findings should be interpreted as hypothesis-generating, and further prospective comparative studies are required to validate the protocol.Keywords
This publication has 37 references indexed in Scilit:
- Debridement, antibiotics and implant retention: are all approaches to periprosthetic joint infection equal? Same procedures, different outcomesClinical Microbiology and Infection, 2025
- Long-term implant survival after debridement, antibiotics and implant Retention (DAIR) for acute prosthetic joint infections: is it a viable option beyond four weeks after index arthroplasty?International Orthopaedics, 2025
- Efficacy of Adjunctive Antiseptic Lavage Solution in Managing Acute Hip/Knee Prosthetic Joint Infection: A Comparative Study in a Tertiary Revision CenterArthroplasty Today, 2025
- Safety Profile of Seven-Day Intra-articular Antibiotic Irrigation for the Treatment of Chronic Periprosthetic Joint Infection: A Prospective Randomized Phase II Comparative StudyThe Journal of Arthroplasty, 2024
- Outcome of Irrigation and Debridement With Topical Antibiotics Delivery for the Management of Periprosthetic Joint Infection Occurring Within 3 Months Since the Primary Total Joint ArthroplastyThe Journal of Arthroplasty, 2021
- Antiseptics Commonly Used in Total Joint Arthroplasty Interact and May Form Toxic ProductsThe Journal of Arthroplasty, 2018
- One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THAClinical Orthopaedics and Related Research, 2017
- Reinfected Revised TKA Resolves With an Aggressive Protocol and Antibiotic InfusionClinical Orthopaedics and Related Research, 2012
- Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic InfusionClinical Orthopaedics and Related Research, 2011
- Management of Infection Associated with Prosthetic JointsInfection, 2003